Back to search
BRCA or HRR+ Mutated Ovarian Cancer Patients
Clinical trial pipeline · Data from ClinicalTrials.gov
See which BRCA or HRR+ Mutated Ovarian Cancer Patients trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which BRCA or HRR+ Mutated Ovarian Cancer Patients trials you may qualify forNUV-868-01 is a first-in human, open- label, Phase 1/2 dose escalation and expansion study in patients with advanced solid tumors. The Phase 1 and 1b portions i…
This interventional study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of SYN608 as monotherapy in adult…
This is a prospective, open-label, single arm, multi-center study to assess the real world clinical effectiveness and safety of olaparib maintenance monotherapy…